A special interview with Pavan Garikapati, Regulatory Domain Head, Medical Devices, Wipro Ltd.
By Sai Nikesh D
In a move to strengthen the Indian medical devices industry, the Department of Pharmaceuticals (DoP) has come up with a National Medical Device Policy (NMDP) 2015, aimed at promoting ‘Make in India’ in this industry by reducing dependence on imports. A draft was issued by DoP on June 3, 2015, seeking comments prior to implementation. The new National Medical Device Policy intends to set up a strong base for manufacturing of medical devices. It comes during a time when the aforesaid industry is dependent on imports that pour in from First World markets. Pavan Garikapati, Regulatory Domain Head, Medical Devices, Wipro Ltd., shared his opinion on how the Indian medical devices industry is looking at NMDP 2015.
Excerpts of interview:
Question (Q): Are there any notable improvements in the Indian medical devices industry post the issuing of ‘National Medical Devices Policy-2015’ by the Department of Pharmaceuticals?
Pavan Garikapati (PG): Draft NMDP 2015 was released by Department of Pharmaceuticals on June 3, 2015. Three major points of the policy are Promotion of Industry, Promotion of Quality and Promotion of Skills. It is highly commendable to focus on these aspects. This policy has great potential to boost the quality, reliability and competitiveness of the Indian Medical Device industry. However, the details need to be chalked out to implement this policy. The regulations should be aligned to the policy. The policies can be prioritized for a specific category, for e.g. India needs quick and efficient diagnostic devices in addition to preventive or curative devices, at this hour.
This was published in The Dollar Business on June 13, 2015